Among breast cancers, triple-negative breast cancer (TNBC), which lacks the expression of hormone receptors and human epidermal growth factor receptor 2 (HER2), is associated with a higher rate of recurrence and poorer prognosis after surgery and adjuvant chemotherapy (3). The gene discussed is ERBB2; the disease is breast carcinoma.